ABSTRACT
OBJECTIVE: To determine adverse effects of single and multiple doses of liposome-encapsulated cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP) administered IV to healthy adult cats. ANIMALS: 10 healthy adult cats. PROCEDURE: 8 cats were given a single dose of L-NDDP (at rates of 75, 100, 150, or 200 mg/m2), and 2 cats were given liposomal lipid (1,500 mg/m2). Six of the 10 cats were given doses of L-NDDP at the maximum tolerated dosage (100 mg/m2) or a lower dosage (75 mg of L-NDDP/m2) at 21-day intervals, for a total of 4 treatments. Hematologic and serum biochemical analyses, urinalyses, and physical examinations were used to monitor effects of L-NDDP. RESULTS: All cats had transient pyrexia, lethargy, vomiting (1 to 3 times/24 h), inappetence, and an acute species-specific infusion reaction that was prevented by administration of atropine-diphenhydramine. Dose-limiting toxicosis was evident as a 10-day course of lethargy, intermittent vomiting, and diarrhea. In cats given multiple doses, dose-related thrombocytopenia, cumulative myelosuppression, transient increased hepatic transaminase activity, and mild to moderate hepatic hydropic degeneration and proximal renal tubular lipidosis in excess of lipidosis expected for this species were detected. Bone marrow hypoplasia was detected in some cats that received higher doses (cumulative dosages of 300 or 400 mg of L-NDDP/m2). CONCLUSION: Cats can safely be given L-NDDP at potentially therapeutic dosages without inducing renal or pulmonary toxicoses. CLINICAL RELEVANCE: Because L-NDDP has better tumoricidal activity than cisplatin (in vivo and in vitro) and is not cross resistant, it may be similarly or more efficacious than cisplatin in humans and dogs.
Subject(s)
Antineoplastic Agents/toxicity , Cats/physiology , Organoplatinum Compounds/toxicity , Animals , Antineoplastic Agents/administration & dosage , Blood Chemical Analysis/veterinary , Body Temperature , Dimyristoylphosphatidylcholine/pharmacology , Drug Carriers , Female , Indicators and Reagents/pharmacology , Liposomes , Male , Neutrophils/chemistry , Organoplatinum Compounds/administration & dosage , Platelet Count/veterinary , Random Allocation , Statistics, Nonparametric , Urinalysis/veterinaryABSTRACT
A three-year-old wire fox terrier inadvertently was given an intranasal Bordetella bronchiseptica and canine parainfluenza vaccine subcutaneously. The dog subsequently developed both a local inflammatory reaction at the injection site and acute, nonseptic hepatocellular degeneration and necrosis. The patient was treated successfully with intravenous fluids and amikacin. Two months after the injection, the serum bile acid concentrations and hepatic histopathology indicated the presence of continued hepatocellular disease.
Subject(s)
Bordetella bronchiseptica/immunology , Dog Diseases/etiology , Liver Diseases/veterinary , Liver/pathology , Respirovirus/immunology , Viral Vaccines/adverse effects , Administration, Intranasal , Amikacin/therapeutic use , Animals , Anti-Bacterial Agents/therapeutic use , Blood Chemical Analysis/veterinary , Bordetella Infections/immunology , Bordetella Infections/prevention & control , Bordetella Infections/veterinary , Dog Diseases/drug therapy , Dog Diseases/pathology , Dogs , Female , Injections, Subcutaneous/adverse effects , Injections, Subcutaneous/veterinary , Liver Diseases/drug therapy , Liver Diseases/etiology , Necrosis , Paramyxoviridae Infections/immunology , Paramyxoviridae Infections/prevention & control , Paramyxoviridae Infections/veterinary , Viral Vaccines/administration & dosage , Viral Vaccines/immunologyABSTRACT
A congenital intrahepatic portosystemic shunt was successfully closed in a 3-month-old Golden Retriever by use of a transvenous coil embolization procedure. The pup's patent ductus venosus was occluded by placing 8 Dacron fiber-covered, stainless steel, spring embolization coils into the shunt vessel through a catheter placed through the jugular vein. Four separate embolization procedures were performed to gradually close the portosystemic shunt and to allow intrahepatic portal perfusion to reform. Transvenous embolization may prove to be a better therapeutic alternative than surgery for correction of intrahepatic shunts because of its decreased invasiveness, lower mortality, and ability to gradually narrow the shunt lumen.
Subject(s)
Dog Diseases/therapy , Ductus Arteriosus, Patent/veterinary , Embolization, Therapeutic/veterinary , Animals , Dog Diseases/diagnostic imaging , Dogs , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/therapy , Male , Radiography , UltrasonographyABSTRACT
Systemic lupus erythematosus was diagnosed in a dog with concurrent nematode infection. The clinical signs of disease were unusually severe and included multiple neurologic deficits, polyarthritis, and weight loss. The dog was thrombocytopenic, and serotest results included positive lupus erythematosus test, positive rheumatoid factor test, positive antinuclear antibody test, hypergammaglobulinemia, and high platelet-associated IgG concentration. After treatment of hookworm, whipworm, and heartworm infections concurrently with corticosteroid and empiric treatment, the dog's condition improved. However, 10 days later, cyclophosphamide administration was necessary for continued immunosuppression. The dog was euthanatized because of progressive deterioration and development of canine coronavirus diarrhea. Serotest data generated from the dog's serum obtained at the time of referral suggested that autoantibodies and circulating immune complexes may have included IgE isotypes.
